AstraZeneca rejects Pfizer's sweetened $106 billion bid By: San Francisco Business Times via Business Journals May 02, 2014 at 12:10 PM EDT Pfizer Inc. increased its offer for AstraZeneca to $106 billion — but the sweetened bid was immediately rejected... Read More >> Related Stocks: Pfizer